- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 95.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 96.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 94.27M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $100.06M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $2.75M |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$133.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$13.49M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $472.93M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $652.39M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $733.17M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $798.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $676.64M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $633.22M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.23B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.18B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.96B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.97B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $76.07M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $60.56M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $80.11M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $57.84M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.65M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.45M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.52M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.5M |